Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of AZD4901 in Females with Polycystic Ovary Syndrome
2013-000788-98Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in polycystic ovary syndrome (PCOS) comparing AZD4901 arm with Placebo arm (2 arms). Primary endpoint: Primary endpoint: Change from baseline at Day 7 in luteinizing hormone AUC(0-8). Started Apr 2013; status: completed.
02
Drugs
pavinetant
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on 2013-000788-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000788-98.